Selected research
Industry Research
Carbetocin (Duratocin) Industry Research Report 2026
Market perspective
The global Carbetocin (Duratocin) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Carbetocin (Duratocin) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Carbetocin (Duratocin) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Carbetocin (Duratocin) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Carbetocin (Duratocin) include Ferring Inc., Hangzhou Dayangchem Co. Ltd., Acinopeptide Co., Ltd., Polypeptide Laboraries France, Leap Labchem Co., Ltd, Clearsynth Canada INC., Chemos GmbH & Co. KG, Chemieliva Pharmaceutical Co., Ltd. and BOC Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Carbetocin (Duratocin) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Carbetocin (Duratocin) Market by Company
Ferring Inc.
Hangzhou Dayangchem Co. Ltd.
Acinopeptide Co., Ltd.
Polypeptide Laboraries France
Leap Labchem Co., Ltd
Clearsynth Canada INC.
Chemos GmbH & Co. KG
Chemieliva Pharmaceutical Co., Ltd.
BOC Sciences
Beacon Pharmaceuticals Limited
Bachem AG
Acinopeptide Co., Ltd.
Carbetocin (Duratocin) Segment by Type
Carbetocin Tablets
Carbetocin Injection
Carbetocin (Duratocin) Segment by Application
Oxytocic
Antihemorrhagic
Uterotonic
Carbetocin (Duratocin) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbetocin (Duratocin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Carbetocin (Duratocin) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbetocin (Duratocin).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Carbetocin (Duratocin) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Carbetocin (Duratocin) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Carbetocin (Duratocin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Carbetocin Tablets
- Carbetocin Injection
Applications
- Oxytocic
- Antihemorrhagic
- Uterotonic
Companies covered
- Ferring Inc.
- Hangzhou Dayangchem Co. Ltd.
- Acinopeptide Co., Ltd.
- Polypeptide Laboraries France
- Leap Labchem Co., Ltd
- Clearsynth Canada INC.
- Chemos GmbH & Co. KG
- Chemieliva Pharmaceutical Co., Ltd.
- BOC Sciences
- Beacon Pharmaceuticals Limited
- Bachem AG
- Acinopeptide Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Carbetocin (Duratocin) Market Size (2021-2032)
- 2.2.2 Global Carbetocin (Duratocin) Sales (2021-2032)
- 2.2.3 Global Carbetocin (Duratocin) Market Average Price (2021-2032)
- 2.3 Carbetocin (Duratocin) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Carbetocin Tablets
- 2.3.3 Carbetocin Injection
- 2.4 Carbetocin (Duratocin) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oxytocic
- 2.4.3 Antihemorrhagic
- 2.4.4 Uterotonic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Carbetocin (Duratocin) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Carbetocin (Duratocin) Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Carbetocin (Duratocin) Revenue of Manufacturers (2021-2026)
- 3.4 Global Carbetocin (Duratocin) Average Price by Manufacturers (2021-2026)
- 3.5 Global Carbetocin (Duratocin) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Carbetocin (Duratocin), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Carbetocin (Duratocin), Product Type & Application
- 3.8 Global Manufacturers of Carbetocin (Duratocin), Established Date
- 3.9 Global Carbetocin (Duratocin) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ferring Inc.
- 4.1.1 Ferring Inc. Company Information
- 4.1.2 Ferring Inc. Business Overview
- 4.1.3 Ferring Inc. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ferring Inc. Carbetocin (Duratocin) Product Portfolio
- 4.1.5 Ferring Inc. Recent Developments
- 4.2 Hangzhou Dayangchem Co. Ltd.
- 4.2.1 Hangzhou Dayangchem Co. Ltd. Company Information
- 4.2.2 Hangzhou Dayangchem Co. Ltd. Business Overview
- 4.2.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Portfolio
- 4.2.5 Hangzhou Dayangchem Co. Ltd. Recent Developments
- 4.3 Acinopeptide Co., Ltd.
- 4.3.1 Acinopeptide Co., Ltd. Company Information
- 4.3.2 Acinopeptide Co., Ltd. Business Overview
- 4.3.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
- 4.3.5 Acinopeptide Co., Ltd. Recent Developments
- 4.4 Polypeptide Laboraries France
- 4.4.1 Polypeptide Laboraries France Company Information
- 4.4.2 Polypeptide Laboraries France Business Overview
- 4.4.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Polypeptide Laboraries France Carbetocin (Duratocin) Product Portfolio
- 4.4.5 Polypeptide Laboraries France Recent Developments
- 4.5 Leap Labchem Co., Ltd
- 4.5.1 Leap Labchem Co., Ltd Company Information
- 4.5.2 Leap Labchem Co., Ltd Business Overview
- 4.5.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Portfolio
- 4.5.5 Leap Labchem Co., Ltd Recent Developments
- 4.6 Clearsynth Canada INC.
- 4.6.1 Clearsynth Canada INC. Company Information
- 4.6.2 Clearsynth Canada INC. Business Overview
- 4.6.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Clearsynth Canada INC. Carbetocin (Duratocin) Product Portfolio
- 4.6.5 Clearsynth Canada INC. Recent Developments
- 4.7 Chemos GmbH & Co. KG
- 4.7.1 Chemos GmbH & Co. KG Company Information
- 4.7.2 Chemos GmbH & Co. KG Business Overview
- 4.7.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Portfolio
- 4.7.5 Chemos GmbH & Co. KG Recent Developments
- 4.8 Chemieliva Pharmaceutical Co., Ltd.
- 4.8.1 Chemieliva Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Chemieliva Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Portfolio
- 4.8.5 Chemieliva Pharmaceutical Co., Ltd. Recent Developments
- 4.9 BOC Sciences
- 4.9.1 BOC Sciences Company Information
- 4.9.2 BOC Sciences Business Overview
- 4.9.3 BOC Sciences Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BOC Sciences Carbetocin (Duratocin) Product Portfolio
- 4.9.5 BOC Sciences Recent Developments
- 4.10 Beacon Pharmaceuticals Limited
- 4.10.1 Beacon Pharmaceuticals Limited Company Information
- 4.10.2 Beacon Pharmaceuticals Limited Business Overview
- 4.10.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Portfolio
- 4.10.5 Beacon Pharmaceuticals Limited Recent Developments
- 4.11 Bachem AG
- 4.11.1 Bachem AG Company Information
- 4.11.2 Bachem AG Business Overview
- 4.11.3 Bachem AG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bachem AG Carbetocin (Duratocin) Product Portfolio
- 4.11.5 Bachem AG Recent Developments
- 4.12 Acinopeptide Co., Ltd.
- 4.12.1 Acinopeptide Co., Ltd. Company Information
- 4.12.2 Acinopeptide Co., Ltd. Business Overview
- 4.12.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
- 4.12.5 Acinopeptide Co., Ltd. Recent Developments
5 Global Carbetocin (Duratocin) Market Scenario by Region
- 5.1 Global Carbetocin (Duratocin) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Carbetocin (Duratocin) Sales by Region: 2021-2032
- 5.2.1 Global Carbetocin (Duratocin) Sales by Region: 2021-2026
- 5.2.2 Global Carbetocin (Duratocin) Sales by Region: 2027-2032
- 5.3 Global Carbetocin (Duratocin) Revenue by Region: 2021-2032
- 5.3.1 Global Carbetocin (Duratocin) Revenue by Region: 2021-2026
- 5.3.2 Global Carbetocin (Duratocin) Revenue by Region: 2027-2032
- 5.4 North America Carbetocin (Duratocin) Market Facts & Figures by Country
- 5.4.1 North America Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Carbetocin (Duratocin) Sales by Country (2021-2032)
- 5.4.3 North America Carbetocin (Duratocin) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Carbetocin (Duratocin) Market Facts & Figures by Country
- 5.5.1 Europe Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Carbetocin (Duratocin) Sales by Country (2021-2032)
- 5.5.3 Europe Carbetocin (Duratocin) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Carbetocin (Duratocin) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Carbetocin (Duratocin) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Carbetocin (Duratocin) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Carbetocin (Duratocin) Market Facts & Figures by Country
- 5.7.1 South America Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Carbetocin (Duratocin) Sales by Country (2021-2032)
- 5.7.3 South America Carbetocin (Duratocin) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Carbetocin (Duratocin) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Carbetocin (Duratocin) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Carbetocin (Duratocin) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Carbetocin (Duratocin) Sales by Type (2021-2032)
- 6.1.1 Global Carbetocin (Duratocin) Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Carbetocin (Duratocin) Sales Market Share by Type (2021-2032)
- 6.2 Global Carbetocin (Duratocin) Revenue by Type (2021-2032)
- 6.2.1 Global Carbetocin (Duratocin) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Carbetocin (Duratocin) Revenue Market Share by Type (2021-2032)
- 6.3 Global Carbetocin (Duratocin) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Carbetocin (Duratocin) Sales by Application (2021-2032)
- 7.1.1 Global Carbetocin (Duratocin) Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Carbetocin (Duratocin) Sales Market Share by Application (2021-2032)
- 7.2 Global Carbetocin (Duratocin) Revenue by Application (2021-2032)
- 7.2.1 Global Carbetocin (Duratocin) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Carbetocin (Duratocin) Revenue Market Share by Application (2021-2032)
- 7.3 Global Carbetocin (Duratocin) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Carbetocin (Duratocin) Value Chain Analysis
- 8.1.1 Carbetocin (Duratocin) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Carbetocin (Duratocin) Production Mode & Process
- 8.2 Carbetocin (Duratocin) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Carbetocin (Duratocin) Distributors
- 8.2.3 Carbetocin (Duratocin) Customers
9 Global Carbetocin (Duratocin) Analyzing Market Dynamics
- 9.1 Carbetocin (Duratocin) Industry Trends
- 9.2 Carbetocin (Duratocin) Industry Drivers
- 9.3 Carbetocin (Duratocin) Industry Opportunities and Challenges
- 9.4 Carbetocin (Duratocin) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst